BMS-488043 is a novel and unique orally bioavailable small-molecule inhibitor of the attachment of human immunodeficiency virus type 1 (HIV-1) to CD4(+) lymphocytes. References: Habgood M, Sugden IJ, Kazantsev AV, Adjiman CS, Pantelides CC. Efficient Handling of Molecular Flexibility in Ab Initio Generation of Crystal Structures. J Chem Theory Comput. 2015 Apr 14;11(4):1957-69. doi: 10.1021/ct500621v. PubMed PMID: 26574397.

纯度：≥98%

CAS：452296-83-2